Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Q1 Update

8 Jan 2021 07:00

RNS Number : 9950K
Marston's PLC
08 January 2021
 

 

 

 

 

 

8 January 2021

 

MARSTON'S PLC

("Marston's" or "the Company")

 

Q1 Update

 

Marston's PLC issues the following update for the 13 weeks ended 2 January 2021.

 

Trading and Business Outlook

 

During the 13-week period, trading was materially disrupted due to Covid-19 related trading restrictions imposed across England, Scotland and Wales. Total pub revenues for the quarter were £54 million.

 

Following the imposition of lockdowns across the UK in recent days, all our pubs are closed. We do not have certainty about the timing of reopening, but in view of comments from the Prime Minister about the potential for lifting restrictions as the vaccination programme progresses we anticipate that pubs will be closed for trading until March at the earliest, and expect some of the previous restrictions to remain on reopening.

 

Despite this disruption, we remain focused on the strategic development of the business. The joint venture between Carlsberg UK and Marston's Beer Company completed on 30 October 2020 and we received initial proceeds of £233 million which were used to reduce debt. The profit on disposal of Marston's Beer Company into the joint venture is estimated to be around £280 million and the spot value of the contingent payment to be received in October 2021 is approximately £20 million.

 

In December 2020 we exchanged contracts with SA Brain to operate its portfolio of 156 pubs in Wales, on a combination of leased and management contract arrangements. These pubs generated a pre-COVID outlet EBITDA of £14 million from which we will pay rent of £5.5 million per annum with effect from April 2021, representing a 2.5x rent cover. This transaction does not compromise our stated financial strategy of reducing borrowings to below £1 billion by financial year 2024. A more detailed presentation of the transaction will be set out on completion in early February.

 

As we outlined in our preliminary results in December, when restrictions are lifted we expect consumer demand to be strong and that our pub estate, which is predominately located in suburban locations, will be well positioned. The SA Brain transaction demonstrates our commitment to growing our pub business and our confidence in the medium-term outlook for the UK pub sector. 

 

Financing and Liquidity

 

During the quarter we have continued to focus on cash preservation with all non-essential spend avoided. Government support is being accessed through the job retention scheme, with 97% of our employees currently furloughed, and business rates relief. Recently announced grants will be applied for subject to compliance with State Aid rules.

 

Despite the ongoing temporary disruption to trading, we have significant liquidity following the completion of the joint venture. Bank drawings net of cash at 2 January were £104 million, from a £280 million facility which extends to 2024, providing bank facility headroom of £176 million.

 

In addition, within the securitisation we have generated sufficient cash in the period to make scheduled repayments of £18 million which fall due on 15 January. The securitisation also includes a £120 million liquidity facility of which £10 million is currently drawn.  

 

Our providers of finance have continued to demonstrate support by granting waivers and amendments to covenants when requested, and we are confident of receiving their continued support in the future if it is needed.

 

As previously reported, we estimate that our cash burn in full lockdown is £3-4 million per week, before scheduled securitised payments. As a consequence of our having significant liquidity in our financing arrangements, the absence of any near-term refinancing requirements, and in the expectation that the outlook for the second half-year is much more positive, we remain confident in our ability to navigate the current difficult environment.

 

Ralph Findlay, Chief Executive of Marston's commented:

 

"The pub sector has been closed for much of the last nine months and remains in a very difficult position. Regrettably there have been casualties across the sector and It is vital that the Government reviews urgently the opportunity to continue to support pubs as we reopen the economy in the coming weeks. Pubs are viable businesses which are part of the social fabric of Britain and which make a major contribution to the economy and the communities in which they serve. It is vital that they not only survive the short-term crisis but are supported in order to recover and flourish. Extending the business rates holiday and VAT cut for the rest of this year is a minimum requirement.

 

Despite these challenges, Marston's has a significantly strengthened balance sheet following the creation of the joint venture with Carlsberg and the financial headroom to weather the extended period of current trading restrictions. With the roll out of the vaccine programme now underway nationwide, we remain well positioned to rebuild trading momentum once restrictions are lifted, as well as to leverage potential market opportunities open to us. We have a clear strategy in place which leaves us confident for the future of our business over the medium term."

 

 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners Tel: 020 7457 2010/2005

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood

 

 

NOTES TO EDITORS

· Marston's is a leading pub operator with a 40% holding in Carlsberg Marston's Brewing Company

· It has an estate of 1,368 pubs situated nationally, comprising managed, franchised and leased pubs

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKOBKFBKDNDK
Date   Source Headline
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector Declaration
18th Dec 20194:28 pmRNSAnnual Financial Report
12th Dec 20193:52 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSPreliminary Results
25th Nov 20197:00 amRNSCompletion of Disposal
21st Nov 20192:52 pmRNSDirectorate Change
4th Nov 20197:00 amRNSDisposal
1st Nov 20192:24 pmRNSTotal Voting Rights
15th Oct 20197:00 amRNSYear End Trading Update
1st Oct 201910:05 amRNSTotal Voting Rights
2nd Sep 20192:15 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSBoard Changes
24th Jul 20197:00 amRNSTrading Update
10th Jul 201911:15 amRNSBlock listing Interim Review
17th Jun 20193:37 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSInterim results for 26 weeks ended 30 March 2019
4th Mar 201911:51 amRNSTotal Voting Rights
1st Feb 20199:11 amRNSTotal Voting Rights
24th Jan 201910:29 amRNSResult of AGM
23rd Jan 20197:00 amRNSTrading Update for the 16 weeks to 19 January 2019
11th Jan 20198:48 amRNSBlock listing Interim Review
2nd Jan 20192:20 pmRNSTotal Voting Rights
19th Dec 201811:04 amRNSAnnual Financial Report
13th Dec 20183:09 pmRNSDirector/PDMR Shareholding
13th Dec 20183:07 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSPreliminary Results
8th Nov 20188:46 amRNSHolding(s) in Company
6th Nov 20184:19 pmRNSHolding(s) in Company
2nd Nov 20182:39 pmRNSHolding(s) in Company
1st Nov 20183:35 pmRNSHolding(s) in Company
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company
10th Oct 20187:00 amRNSYEAR END TRADING UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.